Immunome to Acquire Antibody-Related Assets and Materials from Atreca
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Immunome to acquire Atreca's antibody-related assets for as much as $12.5m
December 26, 2023 11:54 AM ESTImmunome Inc. (NASDAQ: IMNM) announced today an agreement to acquire a collection of antibody-related assets from fellow biotech Atreca (NASDAQ: BCEL). The news sent Immunome shares higher, while Atreca faced a sharp sell-off.
In a move poised to bolster... More
